Australia's most trusted source of pharma news
Thursday, 27 June 2019
Lost Your Access?
Pharma leaders found wanting
Quality of local leadership slips back in 2018-19.
Bayer pulls prostate drug
Health cancels S100 plans as Bayer withdraws product.
Down-scheduling news awaited
Two months since new OTC category consultation closed.
AbbVie buy's big Aust effects
Likely to enter PBS top five and boost staff numbers.
Bayer joins pan-tumour crowd
TGA awards provisional designation to Viktravi.
Amgen plans Melb staff move
Enters phase one of plan to shift operations to Sydney.
AbbVie names new med director
No news on GM but senior executive confirmed.
Aust breakthrough causing stir
Novartis, GSK, BMS, Pfizer chase cutting edge research.
Women more upbeat in pharma
Survey shows work/life balance improved but not for men.
Best M&A pharmas named
Moodys finds four companies with cash to splash.
NMP review will have limits
Not the 'be all that ends all' pharma might hope: Wilson.
Bayer Consumer gets agile
Business completes restructuring for digital age.
Pfizer wins sedative defence
Generic threatened to infringe patent court decides.
New giant must divest drug
Sale of BMS/Celgene psoriasis treatment will slow wrap-up.
Pharma shifts diversity needle
Survey shows rising faith in employment equity.
Top of the Hill
Pharma tied up in red tape
More new forms fly in face of PM's 'congestion busting'.
New irritable bowel option
Allergan registers treatment for IBS and other constipation.
Keytruda awarded SCLC use
FDA approves MSD's anti-PD-1 under priority review.
Events & Conferences
© 2003 - 2019 Lush Media
Pharma in Focus
Jolly Good Design